Search - tctmd.com

Displaying 221 - 240 of 243

Sort: Relevancy | Date

News Daily News

RE-LY: Dabigatran Shortens Drug Interruption with No Increased Bleeding

Jason Kahn

June 22, 2012

News Daily News

Rivaroxaban May be Cost-Effective for A-fib Patients

L.A. McKeown

June 06, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

News Daily News

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

May 09, 2012

News Daily News

New Oral Anticoagulants Top Warfarin in A-fib Stroke Prevention

May 04, 2012

News Daily News

Risk of Intracranial Hemorrhage, Mortality Lower with Dabigatran in A-fib Patients

L.A. McKeown

April 30, 2012

News Daily News

Provisional Heparin Feasible for Preventing Occlusion in Transradial Catheterization

April 30, 2012

News Daily News

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

Caitlin E. Cox

April 26, 2012

News Conference News ACC 2012

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

Jason Kahn

March 25, 2012

News Daily News

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Jason Kahn

March 05, 2012

News Daily News

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

Caitlin E. Cox

January 17, 2012

News Daily News

New-Onset A-fib After Percutaneous Valve Repair More Common Than Thought

December 13, 2011

News Industry News

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

November 15, 2011

News Industry News

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

November 04, 2011

News Daily News

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Caitlin E. Cox

September 14, 2011

News Daily News

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

L.A. McKeown

September 13, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Conference News

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

August 28, 2011

News Daily News

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Caitlin E. Cox

August 10, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

Advertisement

RE-LY: Dabigatran Shortens Drug Interruption with No Increased Bleeding

Rivaroxaban May be Cost-Effective for A-fib Patients

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

New Oral Anticoagulants Top Warfarin in A-fib Stroke Prevention

Risk of Intracranial Hemorrhage, Mortality Lower with Dabigatran in A-fib Patients

Provisional Heparin Feasible for Preventing Occlusion in Transradial Catheterization

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

New-Onset A-fib After Percutaneous Valve Repair More Common Than Thought

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content